Brooks Life Sciences, a division of Brooks Automation, (Nasdaq: BRKS) provides the life science industry with the most comprehensive sample management solutions, enabling researchers worldwide to accelerate innovation and improve patient health. Brooks offers automated storage solutions, informatics, sample storage services, lab services, as well as consumables and instruments. Additionally, the acquisition of GENEWIZ will create even more value for our expanded customer base, advancing discoveries in this genomics era.
Our cryogenic division delivers solutions to help maintain the cryogenic cold chain, as well as a documented audit trail. In the evolving space of cell therapy and personalized medicine, cryogenic infrastructure that controls and documents time, temperature and chain of custody will be critical in reliable delivery of leading edge treatments to patients.
The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.